000 01426 a2200373 4500
005 20250516074516.0
264 0 _c20120517
008 201205s 0 0 eng d
022 _a1879-1301
024 7 _a10.1016/j.chembiol.2012.01.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKisselev, Alexei F
245 0 0 _aProteasome inhibitors: an expanding army attacking a unique target.
_h[electronic resource]
260 _bChemistry & biology
_cJan 2012
300 _a99-115 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Inflammatory Agents
_xchemistry
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBoronic Acids
_xchemistry
650 0 4 _aBortezomib
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aLactones
_xchemistry
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aPeptides, Cyclic
_xchemistry
650 0 4 _aProtease Inhibitors
_xchemistry
650 0 4 _aProteasome Endopeptidase Complex
_xdrug effects
650 0 4 _aProteasome Inhibitors
650 0 4 _aPyrazines
_xtherapeutic use
700 1 _avan der Linden, Wouter A
700 1 _aOverkleeft, Herman S
773 0 _tChemistry & biology
_gvol. 19
_gno. 1
_gp. 99-115
856 4 0 _uhttps://doi.org/10.1016/j.chembiol.2012.01.003
_zAvailable from publisher's website
999 _c21497878
_d21497878